Business Watch: Evonik announces 3,200 job cuts; AbbVie acquires Apogee for $11 billion

This article from C&EN's Business Watch column covers two major industry developments: Evonik's announcement of 3,200 job cuts as part of a restructuring effort, and AbbVie's acquisition of Apogee Therapeutics for nearly $11 billion. The piece also discusses broader trends in the chemical and pharmaceutical industries, including efforts to extract heavy rare earth elements and other business developments. The article provides analysis of these corporate moves and their implications for the sectors.